captopril has been researched along with quinapril in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (18.97) | 18.7374 |
1990's | 25 (43.10) | 18.2507 |
2000's | 15 (25.86) | 29.6817 |
2010's | 7 (12.07) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, D; Essenburg, AD; Kaplan, HR; Roark, WH; Tinney, FJ | 1 |
Blankley, CJ; Cohen, DM; Essenburg, AD; Fleming, RW; Hinkley, JM; Hoefle, ML; Holmes, A; Klutchko, S; Nordin, I; Werner, AE | 1 |
Abbenante, G; Fairlie, DP; Leung, D | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Haynie, R; Vertes, V | 1 |
Goldstein, RJ | 1 |
Frank, GJ; Knapp, LE; McLain, R; Posvar, E; Rieger, MM; Singer, R | 1 |
Frishman, WH; Greenberg, S | 1 |
Posvar, EL; Sedman, AJ | 1 |
Franchi, F; Puddu, GM | 1 |
Ganten, D; Hellmann, T; Keuneke, C; Metzger, R; Peters, J; Yacullo, R | 1 |
Frishman, WH | 2 |
Frank, GJ | 1 |
Schnaper, HW | 1 |
Rietbrock, N; Thürmann, P | 1 |
Arvola, P; Manninen, V; Nurmi, AK; Pörsti, I; Säynävälammi, P; Vapaatalo, H; Ylitalo, P | 1 |
Holt, P; Najm, J; Sowton, E | 1 |
Pörsti, I; Säynävälammi, P | 1 |
Laitinen, LA; Manninen, V; Nurmi, AK; Pörsti, I; Säynävälammi, P; Seppälä, E; Vapaatalo, H; Ylitalo, P | 1 |
Cohen, DM; Essenburg, AD; Kaplan, HR; Major, TC; Mertz, TE; Ryan, MJ | 1 |
Boucher, DM; Cohen, DM; Kaplan, HR; Olszewski, BJ; Ryan, MJ; Singer, RM; Smith, RD | 1 |
Cruickshank, HE | 1 |
Coca, A; Compte, M; de la Sierra, A; Hernández-Herrero, G; Insa, R; Martínez-Amenós, A; Sierra, C | 1 |
Karlberg, BE; Olsson, AG; Wuttge, DM; Ziedén, B | 1 |
Díez, J; Laviades, C | 1 |
Campana, C; Gavazzi, A; Marioni, R; Montemartini, C | 1 |
Capitán, MC; Gil, A; Lavilla, MP; Mateos, FA; Puig, JG; Ramos, TH | 1 |
Davies, M; Doran, J; Jones, S; Townend, J | 1 |
Aoki, K; Nakajima, T; Setoguchi, M; Yaoka, O | 1 |
Kersten, U; Morisse, B | 1 |
Jacolot, A; Petitjean, O; Tod, M | 1 |
Brown, NJ; Nadeau, JH; Vaughan, DE | 1 |
Kaseda, Y; Kitagawa, S; Sato, S; Takeda, J | 1 |
Beynon, JH; Pathy, MS | 1 |
Benzie, IF; Tomlinson, B | 1 |
Akarawut, W; Lin, CJ; Smith, DE | 1 |
Gmiński, J; Goss, M; Machalski, M; Siemianowicz, K; Stajszczyk, M; Wojakowski, W | 1 |
Gminski, J; Goss, M; Machalski, M; Siemianowicz, K; Wojakowski, W | 2 |
Francis, GS; Gassler, JP | 1 |
Browne, AE; Chatterjee, K; Chou, TM; Deedwania, PC; Glantz, SA; Parmley, WW; Pulukurthy, S; Sudhir, K; Sun, YP; Zhu, BQ | 1 |
Broer, M; Dobos, GJ; Mayer, C; Michalsen, A; Philipp, T; Wenzel, RR | 1 |
Bicket, DP | 1 |
Erinola, M; Tepel, M; van der Giet, M; Zidek, W | 1 |
Pfützner, W; Przybilla, B; Ruëff, F | 1 |
Buczko, W; Chabielska, E; Cylwik, D; Kramkowski, K; Mogielnicki, A | 1 |
Buczko, W; Chabielska, E; Domaniewski, T; Karp, A; Kramkowski, K; Malinowska-Zaprzałka, M; Mogielnicki, A; Opadczuk, A; Wojewódzka-Zelezniakowicz, M | 1 |
Brower, GL; Janicki, JS; Levick, SP | 1 |
Aznaouridis, KA; Karatzis, EN; Lekakis, JP; Papamichael, CM; Protogerou, AD; Stamatelopoulos, KS | 1 |
Chou, J; Debanne, SM; Fang, JC; Mishra, P; Simon, DI; Sipahi, I | 1 |
Shen, S; Shi, Y; Yang, X | 1 |
11 review(s) available for captopril and quinapril
Article | Year |
---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Comparative pharmacokinetics of captopril, enalapril, and quinapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Hypertension; Isoquinolines; Quinapril; Reference Values; Tetrahydroisoquinolines | 1992 |
The treatment of moderate to severe hypertension with ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Multicenter Studies as Topic; Quinapril; Tetrahydroisoquinolines | 1990 |
ACE inhibitors in the elderly.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Hypertension; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 1991 |
[ACE inhibitors and heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Isoquinolines; Lisinopril; Quinapril; Tetrahydroisoquinolines | 1990 |
The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Humans; Hypertension; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 1990 |
The efficacy and safety of quinapril in the treatment of moderate to severe and severe hypertension: comparison to captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Drug Evaluation; Humans; Hypertension; Isoquinolines; Multicenter Studies as Topic; Quinapril; Tetrahydroisoquinolines | 1990 |
Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hypertension; Hypotension; Isoquinolines; Kidney; Quinapril; Tetrahydroisoquinolines; Time Factors | 1989 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Enalapril; Fosinopril; Humans; Lisinopril; Neoplasms; Quinapril; Ramipril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines | 2011 |
15 trial(s) available for captopril and quinapril
Article | Year |
---|---|
The treatment of moderate to severe hypertension with ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Multicenter Studies as Topic; Quinapril; Tetrahydroisoquinolines | 1990 |
The safety and tolerability of quinapril.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Hypertension; Hypotension; Isoquinolines; Kidney; Male; Middle Aged; Potassium; Quinapril; Tetrahydroisoquinolines | 1990 |
Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
Topics: Administration, Oral; Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Middle Aged; Quinapril; Tetrahydroisoquinolines | 1991 |
The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Humans; Hypertension; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 1990 |
The efficacy and safety of quinapril in the treatment of moderate to severe and severe hypertension: comparison to captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Drug Evaluation; Humans; Hypertension; Isoquinolines; Multicenter Studies as Topic; Quinapril; Tetrahydroisoquinolines | 1990 |
Comparison of the efficacy and safety of quinapril vs. captopril in treatment of moderate to severe hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Multicenter Studies as Topic; Quinapril; Random Allocation; Tetrahydroisoquinolines | 1989 |
Effect of long-term antihypertensive therapy with angiotensin converting enzyme inhibitors on red cell sodium transport.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Carrier Proteins; Double-Blind Method; Erythrocytes; Female; Humans; Isoquinolines; Kinetics; Lithium; Male; Membrane Proteins; Middle Aged; Quinapril; Single-Blind Method; Sodium; Sodium-Potassium-Chloride Symporters; Tetrahydroisoquinolines | 1995 |
Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Isoquinolines; Lisinopril; Male; Middle Aged; Myocardium; Quinapril; Tetrahydroisoquinolines | 1994 |
Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure. Quinapril/Captopril Congestive Heart Failure Study Group.
Topics: Aged; Captopril; Double-Blind Method; Echocardiography; Electrocardiography; Female; Heart Failure; Humans; Isoquinolines; Male; Middle Aged; Physical Exertion; Quinapril; Tetrahydroisoquinolines | 1994 |
Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium; Captopril; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Isoquinolines; Lipids; Male; Middle Aged; Quinapril; Single-Blind Method; Tetrahydroisoquinolines | 1994 |
[Treatment of heart failure in dogs with ACe inhibitors: comparison of quinapril and captopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Heart Failure; Isoquinolines; Male; Quinapril; Tetrahydroisoquinolines | 1995 |
Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Bradykinin; Captopril; Female; Humans; Hypertension; Isoquinolines; Male; Plasminogen Activator Inhibitor 1; Quinapril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines; Tissue Plasminogen Activator | 1997 |
An open, parallel group comparison of quinapril and captopril, when added to diuretic therapy, in the treatment of elderly patients with heart failure.
Topics: Activities of Daily Living; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Female; Heart Failure; Humans; Isoquinolines; Male; Quinapril; Severity of Illness Index; Tetrahydroisoquinolines; Walking | 1997 |
[Quality of life and psychosocial factors during treatment with antihypertensive drugs. A comparison of captopril and quinapril in geriatric patients].
Topics: Adaptation, Psychological; Aged; Aged, 80 and over; Antihypertensive Agents; Captopril; Depression; Female; Gender Identity; Humans; Hypertension; Isoquinolines; Life Change Events; Male; Quality of Life; Quinapril; Social Adjustment; Social Support; Tetrahydroisoquinolines | 2001 |
Acute effects of renin-angiotensin system blockade on arterial function in hypertensive patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Brachial Artery; Captopril; Double-Blind Method; Female; Forearm; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Quinapril; Regional Blood Flow; Telmisartan; Tetrahydroisoquinolines | 2007 |
35 other study(ies) available for captopril and quinapril
Article | Year |
---|---|
Synthesis and biological activity of modified peptide inhibitors of angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Chemical Phenomena; Chemistry; Dipeptides; Enalapril; Guinea Pigs; Hypertension, Renal; Indoles; Isoquinolines; Quinapril; Rats; Structure-Activity Relationship; Tetrahydroisoquinolines | 1985 |
Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Isoquinolines; Male; Molecular Conformation; Quinapril; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrahydroisoquinolines | 1986 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Captopril; Enalapril; Gene Expression Regulation; Heart; Hydralazine; Hypertension; Isoquinolines; Kidney; Lisinopril; Male; Quinapril; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrahydroisoquinolines | 1990 |
[Angiotensin-converting enzyme inhibitors in angina pectoris].
Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Enalapril; Humans; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 1988 |
Effects of two structurally different angiotensin-converting enzyme inhibitors, captopril and quinapril (CI-906), in rats with one-kidney deoxycorticosterone-salt hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Desoxycorticosterone; Hypertension, Renal; Isoquinolines; Kidney; Male; Quinapril; Rats; Rats, Inbred Strains; Renin; Tetrahydroisoquinolines | 1986 |
The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Catheterization; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Isoquinolines; Male; Middle Aged; Pulmonary Circulation; Quinapril; Tetrahydroisoquinolines | 1986 |
Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Desoxycorticosterone; Isoquinolines; Male; Nephrectomy; Quinapril; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Tetrahydroisoquinolines | 1987 |
Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dinoprostone; Diuresis; Hypertension; Isoquinolines; Kallikreins; Proline; Prostaglandins; Prostaglandins E; Quinapril; Rats; Tetrahydroisoquinolines; Thromboxane B2 | 1984 |
CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Blood Vessels; Captopril; Dipeptides; Dogs; Enalapril; Guinea Pigs; Heart Rate; Hypertension, Renovascular; In Vitro Techniques; Indoles; Isoquinolines; Muscle Contraction; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Quinapril; Rabbits; Rats; Tetrahydroisoquinolines | 1984 |
Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Dipeptides; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Enalapril; Female; Hypertension; Hypertension, Renal; Hypertension, Renovascular; Indoles; Isoquinolines; Kinetics; Male; Quinapril; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Tetrahydroisoquinolines | 1984 |
Angiotensin converting enzyme inhibitors and the otolaryngologist.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Dose-Response Relationship, Drug; Enalapril; Humans; Hypertension; Isoquinolines; Kidney Diseases; Lisinopril; Otolaryngology; Quinapril; Tetrahydroisoquinolines | 1995 |
Effects of in vitro addition of captopril on copper-induced low density lipoprotein oxidation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Copper; Ethanol; Fosinopril; Humans; In Vitro Techniques; Isoquinolines; Lipoproteins, LDL; Oxidation-Reduction; Quinapril; Tetrahydroisoquinolines | 1995 |
Effect of angiotensin converting enzyme inhibition on plasma endothelin in congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Creatinine; Endothelins; Female; Heart Failure; Heart Rate; Humans; Isoquinolines; Male; Middle Aged; Norepinephrine; Pulmonary Artery; Pulmonary Wedge Pressure; Quinapril; Renin; Stroke Volume; Tetrahydroisoquinolines; Vascular Resistance | 1994 |
[Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Heart Rate; Hypertension; Hypertension, Renal; Isoquinolines; Male; Quinapril; Rats; Rats, Inbred SHR; Rats, Wistar; Tetrahydroisoquinolines | 1993 |
Pharmacokinetic interaction between cefdinir and two angiotensin-converting enzyme inhibitors in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cefdinir; Cephalosporins; Drug Interactions; Half-Life; Isoquinolines; Male; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines | 1996 |
Inhibitory effects of angiotensin-converting enzyme inhibitor on cefroxadine uptake by rabbit small intestinal brush border membrane vesicles.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Captopril; Carrier Proteins; Cephalosporins; Cephradine; Enalapril; Intestine, Small; Isoquinolines; Membrane Transport Proteins; Microvilli; Quinapril; Rabbits; Tetrahydroisoquinolines | 1997 |
Antioxidant power of angiotensin-converting enzyme inhibitors in vitro.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Captopril; Colorimetry; Dose-Response Relationship, Drug; Enalapril; Ferric Compounds; Ferrous Compounds; Fosinopril; Indoles; Isoquinolines; Oxidation-Reduction; Perindopril; Quinapril; Tetrahydroisoquinolines | 1998 |
Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding, Competitive; Captopril; Carrier Proteins; Cell Membrane; Dipeptides; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Isoquinolines; Kidney; Kinetics; Lipid Metabolism; Lipids; Lisinopril; Male; Microvilli; Peptide Transporter 1; Quinapril; Rabbits; Ramipril; Symporters; Tetrahydroisoquinolines | 1999 |
[The influence of angiotensin-converting enzyme inhibitors on collagen content of the aorta wall in experimental hypercholesterolemia].
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Collagen; Connective Tissue; Enalapril; Hypercholesterolemia; Isoquinolines; Male; Quinapril; Rabbits; Tetrahydroisoquinolines | 1999 |
The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Cholesterol; Diet, Atherogenic; Enalapril; Hypercholesterolemia; Isoquinolines; Lipid Peroxidation; Male; Quinapril; Rabbits; Tetrahydroisoquinolines; Thiobarbituric Acid Reactive Substances | 2000 |
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Isoquinolines; Myocardial Infarction; Perindopril; Prodrugs; Quinapril; Ramipril; Stroke; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteriosclerosis; Captopril; Cholesterol; Disease Models, Animal; Isoquinolines; Kinins; Losartan; Male; Nitric Oxide; Quinapril; Rabbits; Receptors, Angiotensin; Tetrahydroisoquinolines; Vasoconstriction; Vasodilation | 2001 |
The influence of angiotensin-converting enzyme inhibitors on the aorta elastin metabolism in diet-induced hypercholesterolaemia in rabbits.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Calcium; Captopril; Cholesterol, Dietary; Dose-Response Relationship, Drug; Elastin; Enalapril; Hypercholesterolemia; Isoquinolines; Male; Quinapril; Rabbits; Tetrahydroisoquinolines | 2001 |
Captopril and quinapril reduce reactive oxygen species.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cells, Cultured; Dose-Response Relationship, Drug; Enalaprilat; Fluoresceins; Fluorescent Dyes; Humans; Isoquinolines; Leukocytes, Mononuclear; Lisinopril; NADPH Oxidases; Quinapril; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tetrahydroisoquinolines | 2002 |
Systemic contact dermatitis due to captopril without cross-sensitivity to fosinopril, quinapril and benazepril.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Dermatitis, Contact; Female; Fosinopril; Humans; Hypertension; Quinapril; Skin Tests; Tetrahydroisoquinolines | 2004 |
The effect of 'tissue' and 'plasma' angiotensin converting enzyme inhibitors on overall haemostatic potentials in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Enalapril; Hemostasis; Male; Perindopril; Quinapril; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrahydroisoquinolines | 2006 |
Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Carotid Arteries; Disease Models, Animal; Enalapril; Fibrillar Collagens; Fibrin; Hemostasis; Male; Perindopril; Platelet Adhesiveness; Platelet Aggregation; Quinapril; Rats; Rats, Wistar; Regional Blood Flow; Tetrahydroisoquinolines; Thromboembolism | 2006 |
Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteriovenous Shunt, Surgical; Captopril; Compliance; Disease Models, Animal; Heart Failure; Hypertrophy, Left Ventricular; Lisinopril; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Myocardial Contraction; Myocardium; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Time Factors; Venae Cavae; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2007 |
Application of quantitative NMR for purity determination of standard ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calibration; Captopril; Carbon; Deuterium Oxide; Enalapril; Enzyme Inhibitors; Hydrogen-Ion Concentration; Imidazolidines; Lisinopril; Magnetic Resonance Spectroscopy; Maleates; Methanol; Quinapril; Reference Standards; Solvents; Stereoisomerism; Tetrahydroisoquinolines | 2015 |